BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28527291)

  • 1. Haplotypes in CCR5-CCR2, CCL3 and CCL5 are associated with natural resistance to HIV-1 infection in a Colombian cohort.
    Vega JA; Villegas-Ospina S; Aguilar-Jiménez W; Rugeles MT; Bedoya G; Zapata W
    Biomedica; 2017 Jun; 37(2):267-273. PubMed ID: 28527291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
    Zapata W; Aguilar-Jiménez W; Pineda-Trujillo N; Rojas W; Estrada H; Rugeles MT
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1594-603. PubMed ID: 24098976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic associations and epistatic effects of the CCR5 promoter and CCR2-V64I polymorphisms on susceptibility to HIV-1 infection in a Northern Han Chinese population.
    Lu J; Sheng A; Wang Y; Zhang L; Wu J; Song M; He Y; Yu X; Zhao F; Liu Y; Shao S; Lan J; Wu H; Wang W
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1369-75. PubMed ID: 23057571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
    Tang J; Shelton B; Makhatadze NJ; Zhang Y; Schaen M; Louie LG; Goedert JJ; Seaberg EC; Margolick JB; Mellors J; Kaslow RA
    J Virol; 2002 Jan; 76(2):662-72. PubMed ID: 11752157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy.
    Machuca MA; Suárez EU; Echeverría LE; Martín J; González CI
    Hum Immunol; 2014 Dec; 75(12):1210-5. PubMed ID: 25312802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
    Viladés C; Broch M; Plana M; Domingo P; Alonso-Villaverde C; Pedrol E; Knobel H; Dalmau D; Peraire J; Gutiérrez C; López A; Sambeat MA; Olona M; Garcia F; Richart C; Gatell JM; Vidal F;
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):132-8. PubMed ID: 17091019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.
    Tang J; Wilson CM; Schaen M; Myracle A; Douglas SD; Kaslow RA;
    AIDS Res Hum Retroviruses; 2002 Apr; 18(6):403-12. PubMed ID: 11958683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
    Gupta A; Padh H
    Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.
    Xu L; Qiao Y; Zhang X; Sun H; Wang J; Sun D; Jia X; Shen C; Zhao Y; Jin Y; Yu Y; Ling H; Wang K; Fu S
    Mol Biol Rep; 2011 Jan; 38(1):327-32. PubMed ID: 20364409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
    Huik K; Avi R; Pauskar M; Kallas E; Jõgeda EL; Karki T; Rüütel K; Talu A; Abel-Ollo K; Uusküla A; Carrillo A; Ahuja SK; He W; Lutsar I
    PLoS One; 2016; 11(6):e0156850. PubMed ID: 27304910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.
    Malhotra R; Hu L; Song W; Brill I; Mulenga J; Allen S; Hunter E; Shrestha S; Tang J; Kaslow RA
    Retrovirology; 2011 Mar; 8():22. PubMed ID: 21429204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
    Gonzalez E; Dhanda R; Bamshad M; Mummidi S; Geevarghese R; Catano G; Anderson SA; Walter EA; Stephan KT; Hammer MF; Mangano A; Sen L; Clark RA; Ahuja SS; Dolan MJ; Ahuja SK
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5199-204. PubMed ID: 11320252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of alleles associated with HIV resistance in Russia.
    Ryabov GS; Kazennova EV; Bobkova MR; Bobkov AF
    Genet Test; 2004; 8(1):73-6. PubMed ID: 15140377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.
    Jaumdally SZ; Picton A; Tiemessen CT; Paximadis M; Jaspan HB; Gamieldien H; Masson L; Coetzee D; Williamson AL; Little F; Gumbi PP; Passmore JS
    Immunology; 2017 Aug; 151(4):464-473. PubMed ID: 28398593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection.
    Shrestha S; Strathdee SA; Galai N; Oleksyk T; Fallin MD; Mehta S; Schaid D; Vlahov D; O'Brien SJ; Smith MW
    J Infect Dis; 2006 Jan; 193(1):16-26. PubMed ID: 16323127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
    Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
    J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.